Artificial intelligence is now designing custom proteins in seconds—a process that once took years—paving the way for cures to diseases like cancer and antibiotic-resistant infections. Australian ...

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food ...

Zipline drones help to deliver blood supplies to hospitals across rural western Rwanda, helping to cut waiting times from ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of ...

In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...

Robert Malone, a member of RFK Jr.'s new CDC vaccine advisory committee, is spreading myths about Amish immunity to ...

In the last year, there has been a surge in proteins developed by AI that will eventually be used in the treatment of ...

Moderna Inc. jumped by 8.83 percent on Tuesday to close at $32.54 apiece as investor sentiment was boosted by a lawsuit filed ...

Merck & Co., Inc. (NYSE:MRK) is one of the 10 best defensive stocks to buy in a volatile market. On July 2, UBS reiterated a ...

South Africa’s health ministry has expressed concern about a persistent campaign of Covid-19 vaccine disinformation ...

In April of that year, patients started appearing at hospitals in the industrial city of Sverdlovsk, now known as ...